Skip to main content

Table 3 Univariate Cox Regression for recurrence using the NLR 2.5 cutoff, stratified by treatment subgroups

From: Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer

 

95.0% CI for HR

Group

P-Value

Hazard Ratio

Lower

Upper

Whole Cohort

0.010

2.029

1.185

3.472

No Treatment

0.123

1.866

0.845

4.123

MMC

0.960

1.025

0.392

2.677

BCG

0.023

3.793

1.203

11.956